|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,492.00 GBX | +1.22% |
|
-4.74% | -17.48% |
| 11/06 | Blue chips shrug off ECB rate rise and Iran worry | AN |
| 11/06 | UK's FTSE 100 rises as financials rebound, Middle East and AI spending worries cap gains | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.3 | 9.74 | 10.71 | 11.72 | 12.49 | |||||
Return on Total Capital | 12.48 | 14.55 | 16.13 | 17.62 | 18.94 | |||||
Return On Equity % | 55.25 | 46.78 | 49.72 | 56 | 70.51 | |||||
Return on Common Equity | 55.19 | 46.63 | 49.23 | 55.73 | 70.63 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 64.63 | 64.4 | 64.89 | 65.02 | 66.29 | |||||
SG&A Margin | 38.97 | 37.36 | 36.13 | 35.16 | 35.15 | |||||
EBITDA Margin % | 30.48 | 31.03 | 31.59 | 32.3 | 33.4 | |||||
EBITA Margin % | 29.76 | 30.48 | 31.12 | 31.94 | 33.13 | |||||
EBIT Margin % | 25.66 | 27.04 | 28.76 | 29.86 | 31.14 | |||||
Income From Continuing Operations Margin % | 20.31 | 19.08 | 19.52 | 20.61 | 21.67 | |||||
Net Income Margin % | 20.31 | 19.1 | 19.44 | 20.5 | 21.53 | |||||
Net Avail. For Common Margin % | 20.31 | 19.1 | 19.44 | 20.5 | 21.53 | |||||
Normalized Net Income Margin | 15.14 | 15.63 | 16.07 | 16.87 | 17.73 | |||||
Levered Free Cash Flow Margin | 19.97 | 23.81 | 18.64 | 20.36 | 22.5 | |||||
Unlevered Free Cash Flow Margin | 21.05 | 25.14 | 20.68 | 22.22 | 24.28 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.52 | 0.58 | 0.6 | 0.63 | 0.64 | |||||
Fixed Assets Turnover | 21.62 | 30.38 | 37.93 | 49.26 | 58.12 | |||||
Receivables Turnover (Average Receivables) | 4.38 | 4.61 | 4.46 | 4.48 | 4.41 | |||||
Inventory Turnover (Average Inventory) | 10.39 | 10.84 | 10.26 | 10.17 | 10.07 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.63 | 0.59 | 0.52 | 0.52 | 0.49 | |||||
Quick Ratio | 0.47 | 0.47 | 0.4 | 0.41 | 0.38 | |||||
Operating Cash Flow to Current Liabilities | 0.54 | 0.46 | 0.45 | 0.46 | 0.47 | |||||
Days Sales Outstanding (Average Receivables) | 83.39 | 79.25 | 81.86 | 81.76 | 82.74 | |||||
Days Outstanding Inventory (Average Inventory) | 35.12 | 33.68 | 35.58 | 35.99 | 36.24 | |||||
Average Days Payable Outstanding | 18.64 | 14.01 | 16.98 | 21.76 | 17.72 | |||||
Cash Conversion Cycle (Average Days) | 99.87 | 98.92 | 100.46 | 95.99 | 101.26 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 191.28 | 179.28 | 188.92 | 186.76 | 304.06 | |||||
Total Debt / Total Capital | 65.67 | 64.19 | 65.39 | 65.13 | 75.25 | |||||
LT Debt/Equity | 184.09 | 156.1 | 150.74 | 146.46 | 238.33 | |||||
Long-Term Debt / Total Capital | 63.2 | 55.89 | 52.17 | 51.07 | 58.98 | |||||
Total Liabilities / Total Assets | 76.74 | 76.28 | 76.95 | 76.85 | 83.8 | |||||
EBIT / Interest Expense | 14.87 | 12.71 | 8.78 | 10.02 | 10.94 | |||||
EBITDA / Interest Expense | 18.3 | 14.93 | 9.86 | 11.02 | 11.87 | |||||
(EBITDA - Capex) / Interest Expense | 18.08 | 14.73 | 9.76 | 10.95 | 11.79 | |||||
Total Debt / EBITDA | 2.7 | 2.48 | 2.2 | 2.11 | 2.24 | |||||
Net Debt / EBITDA | 2.65 | 2.35 | 2.14 | 2.07 | 2.2 | |||||
Total Debt / (EBITDA - Capex) | 2.73 | 2.51 | 2.22 | 2.13 | 2.26 | |||||
Net Debt / (EBITDA - Capex) | 2.68 | 2.39 | 2.17 | 2.09 | 2.22 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1.88 | 18.07 | 7.11 | 2.98 | 1.65 | |||||
Gross Profit, 1 Yr. Growth % | 1.28 | 17.64 | 7.93 | 3.18 | 3.64 | |||||
EBITDA, 1 Yr. Growth % | 1.1 | 20.2 | 11.87 | 5.29 | 5.12 | |||||
EBITA, 1 Yr. Growth % | 1.51 | 20.92 | 12.24 | 5.68 | 5.44 | |||||
EBIT, 1 Yr. Growth % | 6.35 | 24.42 | 14.62 | 6.91 | 6 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 21.77 | 10.94 | 9.56 | 8.72 | 6.89 | |||||
Net Income, 1 Yr. Growth % | 20.18 | 11.08 | 9 | 8.59 | 6.77 | |||||
Normalized Net Income, 1 Yr. Growth % | 7.89 | 21.89 | 10.85 | 8.12 | 6.8 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 19.94 | 11.74 | 10.51 | 10.15 | 8.63 | |||||
Accounts Receivable, 1 Yr. Growth % | -2.51 | 27.29 | -2.45 | 7.74 | -1.1 | |||||
Inventory, 1 Yr. Growth % | 5.42 | 22.13 | 2.91 | 4.09 | -6.04 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -22.75 | -7.19 | -21.77 | -19.34 | -7.02 | |||||
Total Assets, 1 Yr. Growth % | -2.03 | 14.22 | -5.76 | 1.45 | -2.48 | |||||
Tangible Book Value, 1 Yr. Growth % | -13.01 | 9.38 | -4.12 | 1.26 | 9.33 | |||||
Common Equity, 1 Yr. Growth % | 53.98 | 16.83 | -8.37 | 0.61 | -32.03 | |||||
Cash From Operations, 1 Yr. Growth % | 26.32 | 19.1 | 2.33 | 6.15 | 8.74 | |||||
Capital Expenditures, 1 Yr. Growth % | -34.88 | 28.57 | -16.67 | -33.33 | 5 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 14.36 | 35.18 | -15.82 | 12.51 | 12.32 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 12.16 | 35.7 | -11.53 | 10.65 | 11.05 | |||||
Dividend Per Share, 1 Yr. Growth % | 5.96 | 9.64 | 7.69 | 7.14 | 7.14 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -4.08 | 9.68 | 12.46 | 5.02 | 2.31 | |||||
Gross Profit, 2 Yr. CAGR % | -4.36 | 9.15 | 12.68 | 5.53 | 3.41 | |||||
EBITDA, 2 Yr. CAGR % | -4.06 | 10.26 | 14.82 | 7.43 | 4.08 | |||||
EBITA, 2 Yr. CAGR % | -4.03 | 10.81 | 15.34 | 7.79 | 4.42 | |||||
EBIT, 2 Yr. CAGR % | -4.7 | 15.06 | 19.47 | 10.69 | 6.45 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -1.27 | 16.23 | 10.25 | 9.14 | 7.8 | |||||
Net Income, 2 Yr. CAGR % | -1.14 | 15.54 | 10.03 | 8.79 | 7.68 | |||||
Normalized Net Income, 2 Yr. CAGR % | -3.6 | 14.68 | 16.29 | 9.47 | 7.46 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -0.72 | 15.77 | 11.12 | 10.33 | 9.39 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.8 | 11.4 | 11.43 | 2.52 | 3.23 | |||||
Inventory, 2 Yr. CAGR % | 7.98 | 13.47 | 12.11 | 3.5 | -1.11 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -18.9 | -15.33 | -14.79 | -20.56 | -13.4 | |||||
Total Assets, 2 Yr. CAGR % | 0.25 | 5.79 | 3.75 | -2.22 | -0.54 | |||||
Tangible Book Value, 2 Yr. CAGR % | -4.23 | -2.45 | 2.41 | -1.47 | 5.22 | |||||
Common Equity, 2 Yr. CAGR % | 22.15 | 34.12 | 3.47 | -3.99 | -17.31 | |||||
Cash From Operations, 2 Yr. CAGR % | -1.76 | 22.65 | 10.4 | 4.22 | 7.44 | |||||
Capital Expenditures, 2 Yr. CAGR % | -22.82 | -8.5 | 3.51 | -25.46 | -16.33 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 2.65 | 23.92 | 6.74 | -2.68 | 12.41 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 0.85 | 23.03 | 9.62 | -1.06 | 10.85 | |||||
Dividend Per Share, 2 Yr. CAGR % | 4.39 | 7.78 | 8.66 | 7.42 | 7.14 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -1.12 | 2.8 | 8.82 | 9.2 | 3.89 | |||||
Gross Profit, 3 Yr. CAGR % | -1.15 | 2.47 | 8.74 | 9.42 | 4.89 | |||||
EBITDA, 3 Yr. CAGR % | -0.95 | 3.42 | 9.85 | 11.55 | 6.66 | |||||
EBITA, 3 Yr. CAGR % | -0.82 | 3.65 | 10.33 | 12.03 | 7.01 | |||||
EBIT, 3 Yr. CAGR % | -1.12 | 4.16 | 14.68 | 15.13 | 9.11 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 0.99 | 2.65 | 13.96 | 9.74 | 8.39 | |||||
Net Income, 3 Yr. CAGR % | 1.14 | 2.78 | 13.32 | 9.55 | 8.12 | |||||
Normalized Net Income, 3 Yr. CAGR % | 0.22 | 4.24 | 13.14 | 13.5 | 8.58 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 2.01 | 3.27 | 13.99 | 10.8 | 9.76 | |||||
Accounts Receivable, 3 Yr. CAGR % | -3.01 | 4.88 | 6.58 | 10.19 | 1.3 | |||||
Inventory, 3 Yr. CAGR % | 6.07 | 12.5 | 9.83 | 9.37 | 0.22 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -14.12 | -15.17 | -17.53 | -16.34 | -16.28 | |||||
Total Assets, 3 Yr. CAGR % | -0.34 | 4.71 | 1.79 | 2.98 | -2.31 | |||||
Tangible Book Value, 3 Yr. CAGR % | -2.82 | 0.11 | -3.01 | 2.02 | 2.01 | |||||
Common Equity, 3 Yr. CAGR % | 11.54 | 20.35 | 18.13 | 2.5 | -14.43 | |||||
Cash From Operations, 3 Yr. CAGR % | 0.52 | 4.75 | 15.47 | 8.96 | 5.71 | |||||
Capital Expenditures, 3 Yr. CAGR % | -20.63 | -8.5 | -11.31 | -10.61 | -16.45 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 3.61 | 14.05 | 8.78 | 8.63 | 2.08 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 2.31 | 12.78 | 10.07 | 9.96 | 2.82 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.76 | 6.11 | 7.75 | 8.15 | 7.33 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.01 | 3.1 | 4.1 | 3.68 | 6.17 | |||||
Gross Profit, 5 Yr. CAGR % | 1.25 | 3.17 | 4.16 | 3.68 | 6.58 | |||||
EBITDA, 5 Yr. CAGR % | 1.39 | 3.53 | 4.96 | 4.9 | 7.97 | |||||
EBITA, 5 Yr. CAGR % | 1.52 | 3.78 | 5.23 | 5.18 | 8.4 | |||||
EBIT, 5 Yr. CAGR % | 2.33 | 4.53 | 6.5 | 6.59 | 11.32 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 4.9 | -0.29 | 4.6 | 5.2 | 11.46 | |||||
Net Income, 5 Yr. CAGR % | 5.05 | -0.17 | 4.61 | 5.14 | 11.03 | |||||
Normalized Net Income, 5 Yr. CAGR % | 3.44 | 4.79 | 6.21 | 6.16 | 10.83 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 6.51 | 0.9 | 5.56 | 6.04 | 12.12 | |||||
Accounts Receivable, 5 Yr. CAGR % | -4.11 | 4.61 | 2.53 | 3.93 | 5.22 | |||||
Inventory, 5 Yr. CAGR % | 3.9 | 9.42 | 8.45 | 8.81 | 5.32 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -11.86 | -10.84 | -14.39 | -17.37 | -15.9 | |||||
Total Assets, 5 Yr. CAGR % | 0.21 | 4.62 | 1.28 | 1.88 | 0.85 | |||||
Tangible Book Value, 5 Yr. CAGR % | -0.76 | 3.45 | -0.76 | -0.53 | 0.2 | |||||
Common Equity, 5 Yr. CAGR % | 7.32 | 10.5 | 8.24 | 9.95 | 2.42 | |||||
Cash From Operations, 5 Yr. CAGR % | 2.98 | 4.64 | 4.36 | 4.54 | 12.18 | |||||
Capital Expenditures, 5 Yr. CAGR % | -11.3 | -6.73 | -11.74 | -15.71 | -13.35 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -0.43 | 10.42 | 5.59 | 6.95 | 10.22 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -0.95 | 9.69 | 5.88 | 6.94 | 10.38 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.73 | 6.74 | 6.91 | 6.63 | 7.51 |
- Stock Market
- Stocks
- REL Stock
- Financials RELX PLC
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















